RIGI and cancer: Moreover, the inhibition of PTEN (phosphatase and tensin homolog), a tumor suppressor gene frequently mutated, deleted, and functionally inactivated in human cancers, along with RIG-I, has been shown to enhance the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) signaling pathway.